Organization
Bausch + Lomb, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Bausch + Lomb, Inc.
... Corporation Ophthalmology/Optometry:Santos Torres, Jr., MBA, Director of Marketing, Allergy/Anti-Infectives/Anti-Virals, U.S. Pharmaceuticals, Bausch + Lomb Men's Health:Chris Horvath, Director of Marketing, Prostate Cancer, Bayer Pharmaceuticals Medical ...
... LAVAL - Bausch Health Companies Inc. (NYSE/TSX: BHC) ('Bausch Health' or the 'Company' or 'we') today announced its second-quarter 2018 financial ...
... for a trip to Texas. That merited decent glass. I bought Bausch & Lomb 8x42 binoculars. I don't remember the price. They were high-end. Geez, ...
... two complete response letters (CRLs) from the FDA, on 2 November, Bausch + Lomb and Nicox announced that they had received approval for their glaucoma ...
... ROCHESTER - Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of ...
... ROCHESTER - Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of ...
... · Roche · Regeneron · Pfizer · Novartis · Bayer · Bausch & Lomb · Allergan · Alcon · Akorn · Our report provides these ...
... of royalties on Q2 2018 sales of VYZULTATM by global partner Bausch + Lomb, after deduction of royalty payments due by Nicox. The Group recorded ...
... Bausch + Lomb said on Monday that its New Drug Application (NDA) for its ...
... for February 25, 2019 LAVAL, Quebec, July 9, 2018 -- - Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of ...
Subscribe now for full coverage on Bausch + Lomb, Inc.
Start My Free Trial